STA-21, a small molecule STAT3 inhibitor, ameliorates experimental autoimmune encephalomyelitis by altering Th-17/Treg balance

被引:9
作者
Gharibi, Tohid [1 ,2 ,3 ]
Barpour, Nesa [1 ,2 ,3 ]
Hosseini, Arezoo [1 ,2 ]
Mohammadzadeh, Adel [4 ]
Marofi, Faroogh [1 ,2 ]
Ebrahimi-Kalan, Abbas [3 ]
Nejati-Koshki, Kazem [4 ]
Abdollahpour-Alitappeh, Meghdad [5 ,6 ]
Safaei, Sahar [1 ]
Baghbani, Elham [1 ]
Baradaran, Behzad [1 ,2 ]
机构
[1] Tabriz Univ Med Sci, Immunol Res Ctr, Tabriz, Iran
[2] Tabriz Univ Med Sci, Dept Immunol, Tabriz, Iran
[3] Tabriz Univ Med Sci, Fac Adv Med Sci, Dept Neurosci & Cognit, Tabriz, Iran
[4] Urmia Univ Med Sci, Fac Med, Dept Immunol & Genet, Orumiyeh, Iran
[5] Ardabil Univ Med Sci, Pharmaceut Sci Res Ctr, Ardebil, Iran
[6] Larestan Univ Med Sci, Sch Nursing, Dept Nursing, Larestan, Iran
关键词
Multiple sclerosis; EAE; STAT3; STA-21; MULTIPLE-SCLEROSIS; TH17; CELLS; CYTOKINES; IL-17; DIFFERENTIATION; INFLAMMATION; ASSOCIATION; ACTIVATION; GENERATION; PROGRESS;
D O I
10.1016/j.intimp.2023.110160
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background: Numerous studies have demonstrated the role of T helper (Th) 17 and T regulatory (reg) cells and pro-inflammatory and anti-inflammatory cytokines related to these cells in the pathogenesis of MS and its animal model, experimental autoimmune encephalomyelitis (EAE). STAT3 is one of the downstream signaling proteins of IL-23, IL-6, and IL-21 that are required for Th17 cells differentiation. STA-21 is a STAT3 inhibitor that functions by inhibiting STAT3 dimerization and binding to DNA impairing the expression of STAT3 target genes including, ROR & gamma;t, IL-21 and IL-23R that are also required for Th17 cell differentiation. Aim: In this study, we evaluated the effect of STA-21 on EAE Model and investigated how this small molecule can change Th17/Treg balance leading to amelioration of disease. Methods: After EAE induction and treatment with STA-21, its effects were assessed. Major assays were H & E and LFB staining, Flow cytometric analysis, Reverse transcription-PCR (RT-PCR), and ELISA. Results: STA-21 ameliorated the EAE severity and decreased the EAE inflammation and demyelination. It also decreased STAT3 phosphorylation, the proportion of Th17 cells and the protein level of IL-17. In contrast, the balance of Tregs and the level of anti-inflammatory cytokine, IL-10 increased in STA-21-treated mice. Moreover, STA-21 significantly decreased the expression of Th17 related transcription factors, ROR & Gamma;t and IL-23R while FOXP3 expression associated with Treg differentiation was increased. Conclusion: This study showed that STA-21 has therapeutic effects in EAE by reducing inflammation and shifting inflammatory immune responses to anti-inflammatory and can be used as a suitable treatment strategy for the treatment of EAE. The effectiveness of inhibiting or strengthening the functional cells of the immune system by these small molecules in terms of easy to access, simple construction and inexpensive expansion make them as a suitable tool for the treatment of inflammatory and autoimmune diseases.
引用
收藏
页数:8
相关论文
共 40 条
[1]   STA-21, a STAT-3 inhibitor, attenuates the development and progression of inflammation in collagen antibody-induced arthritis [J].
Ahmad, Sheikh Fayaz ;
Ansari, Mushtaq Ahmad ;
Nadeem, Ahmed ;
Zoheir, Khairy M. A. ;
Bakheet, Saleh A. ;
Alsaad, Abdulaziz M. S. ;
Al-Shabanah, Othman A. ;
Attia, Sabry M. .
IMMUNOBIOLOGY, 2017, 222 (02) :206-217
[2]   Pathway and network-based analysis of genome-wide association studies in multiple sclerosis [J].
Baranzini, Sergio E. ;
Galwey, Nicholas W. ;
Wang, Joanne ;
Khankhanian, Pouya ;
Lindberg, Raija ;
Pelletier, Daniel ;
Wu, Wen ;
Uitdehaag, Bernard M. J. ;
Kappos, Ludwig ;
Polman, Chris H. ;
Matthews, Paul M. ;
Hauser, Stephen L. ;
Gibson, Rachel A. ;
Oksenberg, Jorge R. ;
Barnes, Michael R. .
HUMAN MOLECULAR GENETICS, 2009, 18 (11) :2078-2090
[3]   TH17 cytokines in autoimmune neuro-inflammation [J].
Becher, Burkhard ;
Segal, Benjamin M. .
CURRENT OPINION IN IMMUNOLOGY, 2011, 23 (06) :707-712
[4]   Multiple Sclerosis: Immunopathology and Treatment Update [J].
Dargahi, Narges ;
Katsara, Maria ;
Tselios, Theodore ;
Androutsou, Maria-Eleni ;
de Courten, Maximilian ;
Matsoukas, John ;
Apostolopoulos, Vasso .
BRAIN SCIENCES, 2017, 7 (07)
[5]   Immunopathology of multiple sclerosis [J].
Dendrou, Calliope A. ;
Fugger, Lars ;
Friese, Manuel A. .
NATURE REVIEWS IMMUNOLOGY, 2015, 15 (09) :545-558
[6]   Functional and Pathogenic Differences of Th1 and Th17 Cells in Experimental Autoimmune Encephalomyelitis [J].
Domingues, Helena S. ;
Mues, Marsilius ;
Lassmann, Hans ;
Wekerle, Hartmut ;
Krishnamoorthy, Gurumoorthy .
PLOS ONE, 2010, 5 (11)
[7]   CD39+Foxp3+ Regulatory T Cells Suppress Pathogenic Th17 Cells and Are Impaired in Multiple Sclerosis [J].
Fletcher, Jean M. ;
Lonergan, Roisin ;
Costelloe, Lisa ;
Kinsella, Katie ;
Moran, Barry ;
O'Farrelly, Cliona ;
Tubridy, Niall ;
Mills, Kingston H. G. .
JOURNAL OF IMMUNOLOGY, 2009, 183 (11) :7602-7610
[8]   pSTAT1, pSTAT3, and T-bet expression in peripheral blood mononuclear cells from relapsing-remitting multiple sclerosis patients correlates with disease activity [J].
Frisullo, Giovanni ;
Angelucci, Francesco ;
Caggiula, Marcella ;
Nociti, Viviana ;
Iorio, Raffaele ;
Patanella, Agata Katia ;
Sancricca, Cristina ;
Mirabella, Massimiliano ;
Tonali, Pietro Attilio ;
Batocchi, Anna Paola .
JOURNAL OF NEUROSCIENCE RESEARCH, 2006, 84 (05) :1027-1036
[9]   Development of Monocytes, Macrophages, and Dendritic Cells [J].
Geissmann, Frederic ;
Manz, Markus G. ;
Jung, Steffen ;
Sieweke, Michael H. ;
Merad, Miriam ;
Ley, Klaus .
SCIENCE, 2010, 327 (5966) :656-661
[10]   Targeting STAT3 in cancer and autoimmune diseases [J].
Gharibi, Tohid ;
Babaloo, Zohreh ;
Hosseini, Arezoo ;
Abdollahpour-alitappeh, Meghdad ;
Hashemi, Vida ;
Marofi, Faroogh ;
Nejati, Kazem ;
Baradaran, Behzad .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2020, 878